Qube Research & Technologies (QRT)
IRMD icon

Qube Research & Technologies (QRT)’s iRadimed IRMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.03M Buy
83,449
+22,491
+37% +$2.25M 0.01% 1408
2025
Q4 		$5.93M Buy
60,958
+4,132
+7% +$354K 0.01% 1664
2025
Q3 		$4.04M Buy
56,826
+8,289
+17% +$552K ﹤0.01% 1884
2025
Q2 		$2.9M Buy
48,537
+964
+2% +$52.8K ﹤0.01% 2014
2025
Q1 		$2.5M Buy
47,573
+1,182
+3% +$66.4K ﹤0.01% 1869
2024
Q4 		$2.55M Buy
46,391
+12,232
+36% +$644K ﹤0.01% 1782
2024
Q3 		$1.72M Buy
34,159
+11,162
+49% +$515K ﹤0.01% 1814
2024
Q2 		$1.01M Buy
22,997
+6,086
+36% +$259K ﹤0.01% 1889
2024
Q1 		$744K Buy
16,911
+11,426
+208% +$505K ﹤0.01% 2318
2023
Q4 		$260K Buy
5,485
+2,720
+98% +$114K ﹤0.01% 2658
2023
Q3 		$123K Buy
+2,765
New +$128K ﹤0.01% 2588

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IRMD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its iRadimed (IRMD) stake by 37% in Q1 2026, buying an estimated $2.25M and bringing the position to 83,449 shares worth $8.03M. The position accounts for 0.01% of the portfolio, ranked #1408.

Qube Research & Technologies (QRT) first reported a position in IRMD in Q3 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 83,449 shares of iRadimed worth $8.03M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 22,491 iRadimed shares in Q1 2026, an estimated $2.25M.
  • iRadimed made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1408 holding.
  • Qube Research & Technologies (QRT) first reported a position in iRadimed in Q3 2023 and has held it in 11 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.